Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Gynecologic 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 69Triple Negative Breast Neoplasms 32Ovarian Neoplasms 21Neoplasm Metastasis 10Prostatic Neoplasms 8Pancreatic Neoplasms 7Fanconi Anemia, Complementation Group D1 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Advanced Breast Cancer 4Recurrence 3Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Inflammatory Breast Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Triple Negative Metastatic Breast Cancer 1Thyroid Neoplasms 1Thrombocytosis 1Stomach Neoplasms 1Sarcoma 1Radiation Injuries 1Prostatic Neoplasms, Castration-Resistant 1Primary Myelofibrosis 1Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Complete Response 1Ovarian 1

Interventions

Fulvestrant 10Letrozole 4Alpelisib 4ribociclib 3palbociclib 3Paclitaxel 2NVP-BKM120 2volagidemab 1serabelisib 1sapanisertib 1olaparib 1liposomal doxorubicin 1gedatolisib 1exemestane 1dapagliflozin 1capivasertib 1abemaciclib 1Taxes 1Tamoxifen 1Secretin 1STX-478 1Metformin 1Lomustine 1Leuprolide 1Irinotecan 1Imlunestrant 1Goserelin 1Gemcitabine 1Drug Therapy 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × olaparib × Breast × Clear all
NCT04586335 2024-03-21

Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

Haihe Biopharma Co., Ltd.

Phase 1 Terminated
24 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡